Microbial Limits for Herbal Raw Materials: What USP <61> and <62> Require Beyond Total Plate Count

Walk into almost any supplement brand’s incoming QC process in the Midwest and you’ll find the same thing on the desk: a stack of supplier Certificates of Analysis showing Total Aerobic Microbial Count (TAMC) and Total Combined Yeast and Mold Count (TYMC). The numbers look clean — say, 2,400 CFU/g for bacteria, 180 CFU/g for yeast and mold — and the lot gets released to production.

The problem is that TAMC and TYMC are enumeration tests. They count microbial load. They tell you nothing about whether Salmonella or E. coli is present in that ashwagandha root powder you just received from a South Asian supplier.

This is the gap between USP <61> and USP <62>. And it’s a gap that FDA has been documenting in enforcement actions and voluntary recalls for years. Between 2022 and 2025, dozens of dietary supplement lots were recalled due to pathogen contamination — including botanical products where the supplier-issued COA showed completely acceptable plate count results. A TAMC of 3,000 CFU/g doesn’t mean the lot is Salmonella-free. It means the plate count is low.

What USP <61> Actually Measures

USP <61>, “Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests,” is a quantitative test. You’re getting two numbers: the total aerobic microbial count and the total combined yeast and mold count.

The methodology uses validated culture plating — pour-plate or membrane filtration onto appropriate selective agars, incubated at 30–35°C for bacteria and 20–25°C for fungi, read after 5 days. It’s the foundational layer of microbiological QC for any nonsterile product.

For herbal raw materials used in dietary supplements intended for internal use without heat processing, the accepted standard under USP guidance is TAMC ≤ 10,000 CFU/g and TYMC ≤ 1,000 CFU/g. Most manufacturers apply these as incoming component specifications, which satisfies the documentation requirement under 21 CFR Part 111 — on paper.

But here’s what that number doesn’t tell you: Salmonella can be present in a dried botanical matrix at a level completely undetectable by plate count. The organism doesn’t have to be abundant to be dangerous. A single contaminated serving dose, even with a background TAMC of a few hundred CFU/g, can cause serious illness in immunocompromised consumers. Enumeration tests aren’t designed to find it.

The Specified Organism Tests in USP <62>

USP <62>, “Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms,” runs absence/presence tests for specific pathogens and indicator organisms. These are not counting tests — they’re designed to detect target organisms even when present at trace levels, using selective enrichment to amplify signal before any identification attempt.

For herbal dietary supplement raw materials consumed without heat treatment, the relevant specified organisms and limits are:

• Salmonella spp. — Absence in 10g
• Escherichia coli — Absence in 1g
• Staphylococcus aureus — Absence in 1g
• Bile-tolerant gram-negative bacteria — ≤ 100 CFU/g (indicator organisms for fecal contamination risk)
• Pseudomonas aeruginosa — Absence in 1g for products with mucous membrane contact potential

The detection workflow for Salmonella alone involves multiple sequential steps: a 24-hour pre-enrichment in buffered peptone water, transfer to selective enrichment broths like Rappaport-Vassiliadis Soy Broth and Selenite Cystine Broth, plating onto selective differential agars (XLD or Hektoen Enteric), and biochemical or immunological confirmation of suspect colonies. From sample receipt to confirmed result, traditional culture methods take 5–7 business days for Salmonella.

An analytical testing lab running both <61> and <62> on a single botanical submission can return a complete microbial panel — all enumeration counts plus specified organism results — in that same window. Rapid PCR screening methods (the BAX® System, 3M™ Molecular Detection, or VIDAS® are common platforms) can cut presumptive Salmonella turnaround to under 24 hours. But presumptive positives require culture confirmation before lot disposition. A negative PCR result on a validated method, though, is generally accepted by FDA as equivalent to culture for clearance purposes.

None of this happens on a typical supplier COA.

Why Botanical Raw Materials Carry Elevated Microbial Risk

Not all supplement ingredients carry the same microbial hazard profile. Herbal botanicals sit at the higher end of the spectrum, and there are specific reasons worth understanding when you’re making risk-based decisions about your incoming testing program.

Soil contact is the primary driver for roots and rhizomes. Ashwagandha root, valerian, eleuthero, black cohosh, and burdock come with inherent soil-borne contamination potential — soil being a natural reservoir for Salmonella, Clostridia, and fecal coliforms. What makes this particularly difficult to manage is Salmonella’s documented ability to survive in low water activity environments. Dried root powders typically reach water activity values below 0.60, a condition under which Salmonella can persist for 12 months or longer without significant die-off. Time on the shelf isn’t controlling the hazard.

Tropical spice-type botanicals have a documented regulatory record. Turmeric, black pepper, cumin, and ginger have appeared in FDA import alerts and 483 observation notes with notable frequency. Contamination typically originates during post-harvest field drying in high-humidity equatorial environments, then carries through milling and bagging. These botanicals are also used as flavoring or matrix agents in herbal formulas — not always the active ingredient, but they’re in the product.

High-moisture berries skew toward elevated yeast and mold. Elderberry, schisandra, hawthorn berry, and similar dried-fruit ingredients often show elevated TYMC even when TAMC is within limits. If a lot comes in at 780 CFU/g on yeast and mold — within the ≤ 1,000 CFU/g spec but trending high — that’s worth a species-level identification. TYMC tells you there’s mold present. It doesn’t tell you whether you’re looking at an environmental Penicillium or an ochratoxin-producing Aspergillus strain.

Processing claims are often unsubstantiated. We regularly see supplier COAs flagging materials as “spray-dried” or “hot water extracted,” implying some degree of thermal lethality. But absent a validated time-temperature profile demonstrating at least a 5-log reduction for Salmonella, that processing notation doesn’t constitute a control. FDA expects documented evidence of lethality — not a box checked on a COA template.

What an Analytical Testing Lab Finds — and What the COA Missed

Here’s a scenario that comes up with enough regularity that it shouldn’t surprise anyone. A Chicago-area supplement brand formulating an adaptogen complex receives a lot of ashwagandha root powder with a supplier COA showing TAMC 2,400 CFU/g and TYMC 180 CFU/g — both well within spec. The quality team reviews the document and releases the lot.

What the COA doesn’t disclose: whether the laboratory that generated those numbers holds ISO 17025 accreditation or any equivalent third-party validation, whether USP <62> specified organism testing was run at all, and whether the sample submitted for testing was genuinely representative of the shipment.

When we run a full USP <61>/<62> panel on incoming botanical lots — samples arrive at our Countryside, IL receiving hub and are tested at our ISO 17025-accredited California testing facility — we do encounter Salmonella-positive results on materials that had clean TAMC/TYMC data on the supplier COA. It doesn’t happen on every lot. But it happens often enough that reviewing the plate count and moving on is not a defensible quality decision.

Under 21 CFR Part 111 §111.70(b), dietary supplement manufacturers must establish component specifications that address contamination with harmful microorganisms. Under §111.75(a), they must verify those specifications are met before using a component. That’s independent incoming testing — not review of a supplier-provided document.

Building a Defensible Microbial Testing Protocol for Raw Materials

A risk-appropriate program doesn’t require full pathogen panels on every lot of every botanical indefinitely. But it does require a documented, rational framework. Here’s the structure we recommend for Midwest brands managing multiple botanical inputs:

1. Classify materials by microbial risk tier. Tier 1 — underground plant parts, tropical spice-type botanicals, any material with a prior positive history — gets the full USP <61>/<62> panel on every received lot. Tier 2 — above-ground parts from qualified suppliers with a clean track record — TAMC/TYMC on every lot, with full <62> specified organism testing every 3rd–5th lot. Tier 3 — highly processed extracts with validated thermal kill steps — TAMC/TYMC with annual <62> verification.

2. Qualify your supplier’s laboratory. Request their ISO 17025 scope of accreditation or equivalent documentation. Confirm they’re running USP-compendial methods or validated AOAC equivalents for specified organism testing. A COA generated by an unaccredited general food testing lab without supplement-specific method validation isn’t equivalent to a USP-compliant result — and FDA auditors know the difference.

3. Use incoming testing as a system, not a spot check. Run full microbial panels on at least the first 3–5 lots from any new supplier before moving to reduced-frequency testing. Maintain a lot-history database by commodity and supplier. A supplier whose TAMC values are trending upward over 6 months is telling you something about their process control.

4. Investigate elevated TYMC before releasing a lot. If yeast and mold counts are within specification but approaching the upper limit, species identification is worth the additional test cost. Knowing the organism helps you understand the source — storage conditions, transit, production environment — and supports a more defensible disposition decision.

5. Maintain contemporaneous testing records per 21 CFR Part 111 §111.260. That means method validation documentation, analyst credentials, instrument calibration logs, and raw data — not just the summary number on a COA. If FDA requests your component testing records in an inspection, the standard is original records. A folder of supplier PDFs doesn’t meet it.

---

Relying on a supplier’s total plate count to stand in for pathogen testing isn’t a risk management strategy — it’s a documented gap in your quality system. USP <62> specified organism testing for herbal raw materials is the minimum a DSHEA-compliant incoming material program requires. If your current protocol stops at TAMC and TYMC, the place to start is a full microbial panel on your highest-risk botanical inputs. Do that before your next FDA inspection makes it a 483 observation.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• Botanical Identity and Purity Testing at Qalitex Laboratories — ISO 17025-accredited USP <61>/<62> microbial panels, ICP-MS heavy metals, and HPTLC botanical identity testing for US-based supplement manufacturers.